Filing Flows › Rockwell Medical (RMTI) › Q2 2026 › vs Q1 2026
Rockwell Medical (RMTI) Q2 2026 vs Q1 2026 (quarter over quarter)
Rockwell Medical's revenue rose $444K (+3%) from $17.3M in Q1 2026 to $17.8M in Q2 2026.
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 8.2% | -3.4% | +11.6 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $17.8M | $17.3M | $444K | +3% |
| Net loss | $1.2M | $1.6M | −$433K | -27% |
| Costs & expenses | $19.0M | $18.9M | $11K | +0.1% |
| Operating costs | $18.8M | $18.8M | $25K | +0.1% |
| Interest & other, net | $111K | $125K | −$14K | -11% |
| Cost of revenue | $14.5M | $14.4M | $98K | +0.7% |
| Sales & marketing | $577K | $567K | $10K | +2% |
| General & admin | $3.7M | $3.8M | −$123K | -3% |
| Operating cash sources | $3.3M | $1.4M | $1.8M | +126% |
| Depreciation & amortization | $492K | $511K | −$19K | -4% |
| Share-based compensation | $403K | $479K | −$76K | -16% |
| Working capital & other | $2.4M | $448K | $1.9M | +426% |
| Net loss absorbed | $1.2M | $1.6M | −$433K | -27% |
| Operating cash flow | $2.1M | −$167K | $2.2M | — |
| Free cash flow (OCF − capex) | $1.5M | −$592K | $2.1M | — |
| Capital expenditures | $617K | $425K | $192K | +45% |
Questions
How much did Rockwell Medical's revenue grow quarter over quarter in Q2 2026?
Rockwell Medical's revenue rose $444K (+3%) from $17.3M in Q1 2026 to $17.8M in Q2 2026.